3 ASX small caps that should be in your portfolio for the 2020s

These 3 ASX small caps, including Bubs Australia Ltd (ASX:BUB), should be in your portfolio for the 2020s.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

You could find the best opportunities for growth on the ASX in the hunting ground of small caps. 

It's much easier for a business to double in size from $250 million to $500 million than it is to go from $2.5 billion to $5 billion.

Over the long-term I think the shares that have got the best potential for returns are either the ones with the greatest economic moats, or the ones that are quite small and have a long growth runway.

Here are three of my favourite small cap ideas for growth:

Bubs Australia Ltd (ASX: BUB

Bubs is an infant formula business, except most of its revenue comes from goat milk products. I have been impressed by what Bubs achieved in its short time on the ASX.

It acquired NuLac Foods, which gave it exclusive supply from the country's biggest goat milking herd. It acquired Australia Deloraine Diary, a CNCA approved infant formula manufacturing facility. It has signed a number of agreements to expand its sales reach, the deals with Chemist Warehouse and Alibaba's Tmall seem particularly clever.

Bubs is launching into new countries and launching new products regularly. The organic (cow) grass-fed formula products could be particularly attractive to consumers over time. 

Bubs is set up for strong long-term growth and its revenue is rising rapidly.

Propel Funeral Partners Ltd (ASX: PFP

Propel is the second largest funeral operator in Australia and New Zealand. It's much smaller than InvoCare Limited (ASX: IVC), so it has a much longer acquisition growth runway before its market share becomes an issue for competition regulators.

The funeral industry has a compelling growth future. Death volumes are expected to grow by 1.4% per annum between 2016 to 2025 and then increase by 2.2% per annum from 2025 to 2050.

When you combine that organic volume growth of the industry with the rising price of funerals, hopefully better profit margins, plus acquisitions, it should lead to good earnings growth over the next decade.

WAM Microcap Limited (ASX: WMI

Finding good small caps can be difficult. It can be tough getting the right price and it may also be hard to know what the right position size for your portfolio is.

I'm happy to leave a lot of my small cap investing to one of the best small cap investing teams in Australia, WAM Microcap.

Since the listed investment company (LIC) was formed in June 2017, its portfolio has produced an average return per annum of 21.9% before fees, expenses and taxes. That's a great performance and I think WAM Microcap could be one of the best fund performers over the next decade.

Foolish takeaway

Propel is definitely the defensive pick of the three, I wouldn't be surprised to see its dividend rise consistently over the next 10 years. Bubs definitely has the potential to be one of the best-performing shares this decade. But WAM Microcap's performance has been really strong and it gives a lot of diversification in a single investment.

Motley Fool contributor Tristan Harrison owns shares of WAM MICRO FPO. The Motley Fool Australia has recommended BUBS AUST FPO, InvoCare Limited, and Propel Funeral Partners Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

A male ASX investor sits cross-legged with a laptop computer in his lap with a slightly crazed, happy, excited look on his face while next to him a graphic of a rocket shoots upwards with graphics of stars scattered around it
Healthcare Shares

Up 10x since July, could this hot ASX stock be the next Droneshield?

Investors chase asymmetric upside and 4DMedical is one of the ASX's hottest stocks right now.

Read more »

A bland looking man in a brown suit opens his jacket to reveal a red and gold superhero dollar symbol on his chest.
Growth Shares

3 ASX mid-cap rockets that could become future blue chips

These stocks could be destined for big things in the future according to analysts.

Read more »

People with their hands underneath each other's hands holding a plant.
Growth Shares

2 ASX growth shares I'd buy today for growth and income

Both of these businesses are delivering excellent progress.

Read more »

A man has a surprised and relieved expression on his face.
Growth Shares

These exciting ASX 200 growth shares could rise 60% to 100% in 2026

Analysts believe these shares could be dirt cheap and strong buys right now.

Read more »

Military soldier standing with army land vehicle as helicopters fly overhead.
Growth Shares

After falling 50%, this under-the-radar growth stock looks like brilliant value to me

A big pullback and rising momentum make EOS one to watch.

Read more »

A woman wearing dark clothing and sporting a few tattoos and piercings holds a phone and a takeaway coffee cup as she strolls under the Sydney Harbour Bridge which looms in the background.
Growth Shares

The best Australian stocks to buy today and not check again until 2035

Let's see which shares analysts are tipping to deliver big returns for investors.

Read more »

A businessman compares the growth trajectory of property versus shares.
Growth Shares

The ASX stocks I think could define the next decade of growth

Analysts are recommending these growth machines to clients.

Read more »

a man in a green and gold Australian athletic kit roars ecstatically with a wide open mouth while his hands are clenched and raised as a shower of gold confetti falls in the sky around him.
Growth Shares

Top Australian stocks to buy right now with $2,000

There are good reasons why these shares are rated as buys by brokers.

Read more »